SILENCE THERAPEUTICS PLC-ADR (SLN) Stock News

USA - Nasdaq - NASDAQ:SLN - US82686Q1013 - ADR

6.44 USD

+0.18 (+2.88%)

Last: 12/11/2025, 8:07:28 PM

6.52 USD

+0.08 (+1.24%)

After Hours: 12/11/2025, 8:07:28 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SLN Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: The Motley Fool - Mentions: BHC RSG VZ RBC

Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake

a month ago - By: Silence Therapeutics plc

Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference

a month ago - By: Silence Therapeutics plc

Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

4 months ago - By: The Motley Fool

Silence (SLN) Q2 Revenue Drops 71%

9 months ago - By: Benzinga

Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings)

10 months ago - By: Benzinga - Mentions: SSP CLCO CVEO DCI ...

Earnings Scheduled For February 27, 2025

2 months ago - By: Silence Therapeutics plc

Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV)

3 months ago - By: Silence Therapeutics plc

Silence Therapeutics to Participate in September Investor Conferences

4 months ago - By: Silence Therapeutics plc

Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights

6 months ago - By: Silence Therapeutics plc

Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera

6 months ago - By: Zacks Investment Research

Wall Street Analysts Think Silence Therapeutics (SLN) Could Surge 556.19%: Read This Before Placing a Bet

7 months ago - By: Zacks Investment Research

Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Here's is How to Trade

7 months ago - By: Silence Therapeutics plc

Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

7 months ago - By: Silence Therapeutics plc

Silence Therapeutics Welcomes Tim McInerney to Board of Directors

8 months ago - By: Yahoo Finance - Mentions: ERJ PYPL BKR VRNA ...

Silence Therapeutics plc (SLN): Among Takeover Rumors Hedge Funds Are Buying

9 months ago - By: Silence Therapeutics plc

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

10 months ago - By: Silence Therapeutics plc

Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

10 months ago - By: Silence Therapeutics plc

Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025

a year ago - By: Silence Therapeutics plc

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting

a year ago - By: Silence Therapeutics plc

Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference

a year ago - By: Silence Therapeutics plc

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

a year ago - By: Silence Therapeutics plc

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

a year ago - By: Silence Therapeutics plc

Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference